Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

R.I. Lalisang; F.L. Erdkamp; C.J. Rodenburg; C.T. Knibbeler - van Rossum; JW Nortier; A. van Bochove; P.H. Slee; E.E. Voest; J.A. Wils; J. Wals; O.J. Loosveld; A.E. Smals; G.H. Blijham; V.C.G. Tjan-Heijnen; H.C. Schouten

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

R.I. Lalisang
, F.L. Erdkamp
, C.J. Rodenburg
, C.T. Knibbeler - van Rossum
, JW Nortier
, A. van Bochove
, P.H. Slee
, E.E. Voest
, J.A. Wils
, J. Wals
, O.J. Loosveld
, A.E. Smals
, G.H. Blijham
, V.C.G. Tjan-Heijnen
, H.C. Schouten

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	437-445
Number of pages	9
Journal	Breast Cancer Research and Treatment
Volume	128
Issue number	2
Publication status	Published - 2011

Cite this

Lalisang, R. I., Erdkamp, F. L., Rodenburg, C. J., Knibbeler - van Rossum, C. T., Nortier, JW., van Bochove, A., Slee, P. H., Voest, E. E., Wils, J. A., Wals, J., Loosveld, O. J., Smals, A. E., Blijham, G. H., Tjan-Heijnen, V. C. G., & Schouten, H. C. (2011). Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. Breast Cancer Research and Treatment, 128(2), 437-445.

@article{8e76c5e19958445dbdbe3650fc229223,

title = "Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.",

author = "R.I. Lalisang and F.L. Erdkamp and C.J. Rodenburg and \{Knibbeler - van Rossum\}, C.T. and JW Nortier and \{van Bochove\}, A. and P.H. Slee and E.E. Voest and J.A. Wils and J. Wals and O.J. Loosveld and A.E. Smals and G.H. Blijham and V.C.G. Tjan-Heijnen and H.C. Schouten",

year = "2011",

language = "English",

volume = "128",

pages = "437--445",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "2",

}

Lalisang, RI, Erdkamp, FL, Rodenburg, CJ, Knibbeler - van Rossum, CT, Nortier, JW, van Bochove, A, Slee, PH, Voest, EE, Wils, JA, Wals, J, Loosveld, OJ, Smals, AE, Blijham, GH, Tjan-Heijnen, VCG & Schouten, HC 2011, 'Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.', Breast Cancer Research and Treatment, vol. 128, no. 2, pp. 437-445.

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. / Lalisang, R.I.; Erdkamp, F.L.; Rodenburg, C.J. et al.
In: Breast Cancer Research and Treatment, Vol. 128, No. 2, 2011, p. 437-445.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

AU - Lalisang, R.I.

AU - Erdkamp, F.L.

AU - Rodenburg, C.J.

AU - Knibbeler - van Rossum, C.T.

AU - Nortier, JW

AU - van Bochove, A.

AU - Slee, P.H.

AU - Voest, E.E.

AU - Wils, J.A.

AU - Wals, J.

AU - Loosveld, O.J.

AU - Smals, A.E.

AU - Blijham, G.H.

AU - Tjan-Heijnen, V.C.G.

AU - Schouten, H.C.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0167-6806

VL - 128

SP - 437

EP - 445

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -